Loss of ecto-5′ nucleotidase from porcine endothelial cells after exposure to human blood: Implications for xenotransplantation

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1741, Issue 1-2, 2005, Pages 191-198

  Khalpey, Zain ^a   Yuen, Ada H ^a   Kalsi, Kameljit K ^a   Kochan, Zdzislaw ^b   Karbowska, Joanna ^b   Slominska, Ewa M ^b   Forni, Monica ^c   Macherini, Massimo ^d   Bacci, Maria L ^c   Batten, Puspa ^a   Lavitrano, Marialuisa ^e   Yacoub, Magdi H ^a   Smolenski, Ryszard T ^a,b  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Adenosine; Complement; Cytoprotection; Ecto 5 nucleotidase; Xenotransplantation

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE KINASE; ADENOSINE MONOPHOSPHATE DEAMINASE; COMPLEMENT COMPONENT C1S INHIBITOR; DECAY ACCELERATING FACTOR; ECTO 5' NUCLEOTIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; CELL FREE SYSTEM; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EX VIVO STUDY; EXPOSURE; FEMALE; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; MALE; NONHUMAN; PERFUSION; PHENOTYPE; PRIORITY JOURNAL; PURINE METABOLISM; STATISTICAL SIGNIFICANCE; SWINE; TRANSGENICS; WILD TYPE; XENOTRANSPLANTATION;

5'-NUCLEOTIDASE; ADENOSINE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; AORTA; BLOOD; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; GRAFT REJECTION; HUMANS; MALE; PERFUSION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

SUIDAE; SUS SCROFA;

EID: 20644460580     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2005.03.008     Document Type: Article

References (55)

1. F.H. Bach, H. Winkler, C. Ferran, W.W. Hancock, and S.C. Robson Delayed xenograft rejection Immunol. Today 17 1996 379 384
2. P.D. Waterworth, J. Dunning, M. Tolan, E. Cozzi, G. Langford, G. Chavez, D. White, and J. Wallwork Life-supporting pig-to-baboon heart xenotransplantation J. Heart Lung Transplant. 17 1998 1201 1207
3. T. Kobayashi, S. Taniguchi, F.A. Neethling, A.G. Rose, W.W. Hancock, Y. Ye, M. Niekrasz, S. Kosanke, L.J. Wright, D.J. White, and D.K. Cooper Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy Transplantation 64 1997 1255 1261
4. O.P. Minanov, J.H. Artrip, M. Szabolcs, P.A. Kwiatkowski, U. Galili, S. Itescu, and R.E. Michler Triple immunosuppression reduces mononuclear cell infiltration and prolongs graft life in pig-to-newborn baboon cardiac xenotransplantation J. Thorac. Cardiovasc. Surg. 115 1998 998 1006
5. M.D. Baron, B. Pope, and J.P. Luzio The membrane topography of ecto-5′-nucleotidase in rat hepatocytes Biochem. J. 236 1986 495 502
6. A. Delikouras, L.D. Fairbanks, A.H. Simmonds, R.I. Lechler, and A. Dorling Endothelial cell cytoprotection induced in vitro by allo- or xenoreactive antibodies is mediated by signaling through adenosine A2 receptors Eur. J. Immunol. 33 2003 3127 3135
7. J.L. Daval, A. Nehlig, and F. Nicolas Physiological and pharmacological properties of adenosine: therapeutic implications Life Sci. 49 1991 1435 1453
8. M.V. Sitkovsky, D. Lukashev, S. Apasov, H. Kojima, M. Koshiba, C. Caldwell, A. Ohta, and M. Thiel Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors Annu. Rev. Immunol. 22 2004 657 682
9. D.H. Sachs, D.M. Bodine, A.D. Moulton, D.A. Pearson, A.W. Nienhuis, and M. Sykes Tolerance induction using autologous bone marrow modified with an allogeneic class I MHC gene Transplant. Proc. 25 1 Pt. 1 1993 348 349 (Feb)
10. R.E. Billingham, L. Brent, and P.B. Medawar "Actively acquired tolerance" of foreign cells Nature 172 1953 603 606
11. S.S. Lin, M.J. Hanaway, G.V. Gonzalez-Stawinski, C.L. Lau, W. Parker, R.D. Davis, G.W. Byrne, L.E. Diamond, J.S. Logan, and J.L. Platt The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts Transplantation 70 2000 1667 1674
12. A. Wu, K. Yamada, D.M. Neveille, M. Awwad, J.C. Wain, R. Colvin, A. Shimizu, H. Kitamura, S. Gojo, D.K.C. Cooper, M. Sykes, and D.H. Sachs Xenogeneic thymic transplantation in a pig-to-baboon model Transplantation 75 2002 282 291
13. L. Buhler, K. Yamada, H. Kitamura, I.P. Alwayn, M. Basker, J.Z. Appel III, R.B. Colvin, M.E. White-Scharf, D.H. Sachs, S.C. Robson, M. Awwad, and D.K. Cooper Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation Transplantation 72 2001 1743 1752
14. H. Ogawa, M.M. Mohiuddin, D.P. Yin, J. Shen, A.S. Chong, and U. Galili Mouse-heart grafts expressing an incompatible carbohydrate antigen: II. Transition from accommodation to tolerance Transplantation 77 2004 366 373
15. M. Mohiuddin, H. Ogawa, D.P. Yin, and U. Galili Tolerance induction to a mammalian blood group like carbohydrate antigen by syngeneic lymphocytes expressing the antigen: II. Tolerance induction on memory B cells Blood 102 1 2003 229 236 (Jul 1)
16. A. Delikouras, L.D. Fairbanks, A.H. Simmonds, R.I. Lechler, and A. Dorling Endothelial cell cytoprotection induced in vitro by allo- or xenoreactive antibodies is mediated by signaling through adenosine A2 receptors Eur. J. Immunol. 33 2003 3127 3135
17. B.N. Cronstein, R.I. Levin, M. Philips, R. Hirschhorn, S.B. Abramson, and G. Weissmann Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors J. Immunol. 148 1992 2201 2206
18. G.S. Firestein, D.A. Bullough, M.D. Erion, R. Jimenez, M. Ramirez-Weinhouse, J. Barankiewicz, C.W. Smith, H.E. Gruber, and K.M. Mullane Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins J. Immunol. 154 1995 326 334
19. M.G. Bouma, F.A. van den Wildenberg, and W.A. Buurman The anti-inflammatory potential of adenosine in ischemia-reperfusion injury: established and putative beneficial actions of a retaliatory metabolite Shock 8 1997 313 320
20. G.E. Lieberman, G.P. Lewis, and T.J. Peters A membrane-bound enzyme in rabbit aorta capable of inhibiting adenosine-diphosphateinduced platelet aggregation Lancet 2 1977 330 332
21. C.A. Bravery, P. Batten, M.H. Yacoub, and M.L. Rose Direct recognition of SLA- and HLA-like class II antigens on porcine endothelium by human T cells results in T cell activation and release of interleukin-2 Transplantation 60 1995 1024 1033
22. U.O. Solvik, G. Haraldsen, A.E. Fiane, E. Boretti, E. Thorsby, and T.E. Mollnes C1-inhibitor attenuates human serum induced E-selectin expression of pig aortic endothelial cells Transplant. Proc. 33 2001 789 790
23. Z. Kochan, R.T. Smolenski, M.H. Yacoub, and A.-M.L. Seymour Nucleotide and adenosine metabolism in different cell types in human and rat heart J. Mol. Cell. Cardiol. 26 1994 1497 1503
24. R.T. Smolenski, D.R. Lachno, S.J.M. Ledingham, and M.H. Yacoub Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation J. Chromatogr. 527 1990 414 420
25. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
26. A.C. Wilson, R.D. Cahn, and N.O. Kaplan Functions of the two forms of lactic dehydrogenase in the breast muscle of birds Nature 197 1963 331 334
27. R.T. Smolenski, O. Raisky, E.M. Slominska, H. Abunasra, K.K. Kalsi, J. Jayakumar, K. Suzuki, and M.H. Yacoub Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply Circulation 104 2001 I246 I252
28. D. Lukashev, A. Ohta, and M. Sitkovsky Targeting hypoxia-A(2A) adenosine receptor-mediated mechanisms of tissue protection Drug Discovery Today 9 2004 403 409
29. M.V. Sitkovsky Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo Biochem. Pharmacol. 65 2003 493 501
30. H. Kojima, B.T. Jones, J. Chen, M. Cascalho, and M.V. Sitkovsky Hypoxia-inducible factor 1alpha-deficient chimeric mice as a model to study abnormal B lymphocyte development and autoimmunity Methods Enzymol. 381 2004 218 229
31. H. Kojima, M.V. Sitkovsky, and M. Cascalho HIF-1 alpha deficiency perturbs T and B cell functions Curr. Pharm. Des. 9 2003 1827 1832
32. J. Linden Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection Annu. Rev. Pharmacol. Toxicol. 41 2001 775 787
33. J. Sevigny, C. Sundberg, N. Braun, O. Guckelberger, E. Csizmadia, I. Qawi, M. Imai, H. Zimmermann, and S.C. Robson Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation Blood 99 2002 2801 2809
34. K. Enjyoji, J. Sevigny, Y. Lin, P.S. Frenette, P.D. Christie, J.S. Esch, M. Imai, J.M. Edelberg, H. Rayburn, M. Lech, D.L. Beeler, E. Csizmadia, D.D. Wagner, S.C. Robson, and R.D. Rosenberg Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation Nat. Med. 5 1999 1010 1017
35. M. Imai, K. Takigami, O. Guckelberger, E. Kaczmarek, E. Csizmadia, F.H. Bach, and S.C. Robson Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival Transplantation 70 2000 864 870
36. S.C. Robson, E. Kaczmarek, J.B. Siegel, D. Candinas, K. Koziak, M. Millan, W.W. Hancock, and F.H. Bach Loss of ATP diphosphohydrolase activity with endothelial cell activation J. Exp. Med. 185 1997 153 163
37. D. Lukashev, A. Ohta, S. Apasov, J.F. Chen, and M. Sitkovsky Cutting edge: physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo J. Immunol. 173 2004 21 24
38. M. Thiel, C.C. Caldwell, and M.V. Sitkovsky The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases Microb. Infect. 5 2003 515 526
39. L. Morabito, M.C. Montesinos, D.M. Schreibman, L. Balter, L.F. Thompson, R. Resta, G. Carlin, M.A. Huie, and B.N. Cronstein Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides J. Clin. Invest. 101 1998 295 300
40. Y. Kawashima, T. Nagasawa, and H. Ninomiya Contribution of ecto-5′-nucleotidase to the inhibition of platelet aggregation by human endothelial cells Blood 96 2000 2157 2162
41. P. Koszalka, B. Ozuyaman, Y. Huo, A. Zernecke, U. Flogel, N. Braun, A. Buchheiser, U.K. Decking, M.L. Smith, J. Sevigny, A. Gear, A.A. Weber, A. Molojavyi, Z. Ding, C. Weber, K. Ley, H. Zimmermann, A. Godecke, and J. Schrader Targeted disruption of cd73/Ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response Circ. Res. 15 95(8) 2004 521 814
42. A. Delikouras, L.D. Fairbanks, A.H. Simmonds, R.I. Lechler, and A. Dorling Endothelial cell cytoprotection induced in vitro by allo- or xenoreactive antibodies is mediated by signaling through adenosine A2 receptors Eur. J. Immunol. 33 2003 3127 3135
43. U.O. Solvik, G. Haraldsen, A.E. Fiane, E. Boretti, J.D. Lambris, M. Fung, E. Thorsby, and T.E. Mollnes Human serum-induced expression of E-selectin on porcine aortic endothelial cells in vitro is totally complement mediated Transplantation 72 2001 1967 1973
44. K.T. Lappegard, M. Fung, G. Bergseth, J. Riesenfeld, and T.E. Mollnes Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition Ann. Thorac. Surg. 78 2004 38 44
45. T.E. Mollnes, and A.E. Fiane Perspectives on complement in xenotransplantation Mol. Immunol. 40 2003 135 143
46. T.E. Mollnes, O.L. Brekke, M. Fung, H. Fure, D. Christiansen, G. Bergseth, V. Videm, K.T. Lappegard, J. Kohl, and J.D. Lambris Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation Blood 100 2002 1869 1877
47. C. Schroder, S. Pfeiffer, G. Wu, G.L. Zorn III, L. Ding, C. Allen, R.A. Harrison, D.J. White, A.M. Azimzadeh, and R.N. Pierson III Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood J. Heart Lung Transplant. 22 2003 1365 1375
48. R.D. Lasley, and E.J. Smart Cardiac myocyte adenosine receptors and caveolae Trends Cardiovasc. Med. 11 2001 259 263
49. A. Kittel, E. Kaczmarek, J. Sevigny, K. Lengyel, E. Csizmadia, and S.C. Robson CD39 as a caveolar-associated ectonucleotidase Biochem. Biophys. Res. Commun. 262 1999 596 599
50. J. Niemela, T. Henttinen, G.G. Yegutkin, L. Airas, A.M. Kujari, P. Rajala, and S. Jalkanen IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5′-nucleotidase) up-regulation J. Immunol. 172 2004 1646 1653
51. A.C. Skladanowski, R.T. Smolenski, M. Tavenier, J.W. de Jong, M.H. Yacoub, and A.M. Seymour Soluble forms of 5′-nucleotidase in rat and human heart Am. J. Physiol. 270 1996 H1493 H1500
52. R. Franco, E.I. Canela, and J. Bozal Heterogeneous localization of some purine enzymes in subcellular fractions of rat brain and cerebellum Neurochem. Res. 11 1986 423 435
53. A. Lewandowicz, P.C. Tyler, G.B. Evans, R.H. Furneaux, and V.L. Schramm Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase J. Biol. Chem. 278 2003 31465 31468
54. J. Sevigny, C. Sundberg, N. Braun, O. Guckelberger, E. Csizmadia, I. Qawi, M. Imai, H. Zimmermann, and S.C. Robson Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation Blood 99 2002 2801 2809
55. R.T. Smolenski, O. Raisky, E.M. Slominska, H. Abunasra, K.K. Kalsi, J. Jayakumar, K. Suzuki, and M.H. Yacoub Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply Circulation 104 2001 I246 I252